Key facts
- This page summarizes Chicago Pacific Founders UGP III, LLC's Form 4 filing for P3 Health Partners Inc. (PIII).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 31 Jan 2025, 19:05.
Chicago Pacific Founders UGP III, LLC - 12 Dec 2024 Form 4 Insider Report for P3 Health Partners Inc. (PIII)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- PIII
- Reported as of
- 12 Dec 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 31 Jan 2025, 19:05:33 UTC
- Prior SEC filing
- 13 Sep 2024
- Next SEC filing
- 06 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- Chicago Pacific Founders UGP III, LLC, /s/ Michael Wilson, authorized signatory
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Chicago Pacific Founders UGP III, LLC filed Form 4 for P3 Health Partners Inc. (PIII) on 31 Jan 2025.
Change
- Previous filing in this sequence was filed on 13 Sep 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PIII
transaction
Derivative
Warrant to Purchase Class A Common Stock
Purchase
- Transaction value
- $0
- Shares
- +71,406,480
- Change %
- Price
- $0.000000
- Shares after
- 71,406,480
- Date
- 12 Dec 2024
- Ownership
- See Footnote
- Underlying class
- Class A Common Stock
- Underlying amount
- 71,406,480
- Exercise price
- $0.2137
- Footnotes
- F1, F2, F3, F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
On December 12, 2024, P3 Health Group, LLC ("P3 LLC"), a subsidiary of P3 Health Partners Inc. (the "Issuer"), entered into a financing transaction with VBC Growth SPV 3, LLC, a Delaware limited liability company ("VBC"), consisting of an unsecured promissory note and warrants to purchase 71,406,480 shares of Class A Common Stock of the Issuer to VBC.
Footnote F2
Exercisable immediately.
Footnote F3
The warrants and the right to purchase securities upon the exercise of the warrants will terminate upon the earliest to occur of the following: (a) December 12, 2031; and (b) the consummation of (i) a sale, conveyance, disposal, or encumbrance of all or substantially all of the Issuer's or P3 LLC's property or business or the Issuer's or P3 LLC's merger into or consolidation with any other corporation (other than a wholly owned subsidiary corporation) or (ii) any other transaction or series of related transactions in which more than fifty percent (50%) of the voting power of the Issuer or P3 LLC is disposed of.
Footnote F4
The warrants were issued in connection with a promissory note issued by the P3 LLC to VBC providing for a financing in several tranches up to an aggregate of $25 million.
Footnote F5
Chicago Pacific Founders UGP III, LLC ("UGP") is the general partner of Chicago Pacific Founders GP III, LP, the Manager of VBC which has the power to vote and dispose of the Issuer's securities held by VBC. Affiliates of VBC also own a 66.81% member interest in VBC.